Cancer screenings can save lives by detecting cancer early, when treatment is most effective.With an estimated 2 mil ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Cancer survivors want to see more access to screenings that they call "a game changer." It's called biomarker testing, which analyzes a patient's tissue, blood or other bodily fluids to help pinpoint ...

Weill Cornell Medicine researchers have discovered that cancer-induced blood clots originate from signals in the lungs, not ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the ...

NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.

There are hopes this discovery and algorithm could be turned into a blood test for IBD patients and other people at high risk of bowel cancer. Currently, the half a million Brits with IBD are ...